Ingevity (NGVT)
NYSE Market Closed
Ingevity Corporation is a US-based specialty chemicals and materials company serving industrial, transportation, energy, infrastructure, and consumer-related markets. The company develops products that are typically used as performance-enhancing inputs rather than finished consumer goods, making its business closely tied to customer needs in manufacturing, mobility, construction, and environmental applications.
Ingevity reports its activities through three main segments: Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. Performance Chemicals is a major revenue contributor and supplies specialty products used in asphalt paving, oilfield applications, agrochemicals, adhesives, lubricants, publication inks, and other industrial processes. These products are designed to improve durability, processing efficiency, dispersion, adhesion, or other functional characteristics.
The Advanced Polymer Technologies segment focuses on caprolactone and caprolactone-based specialty polymers. These materials are used in applications where flexibility, toughness, biodegradability potential, or specialized performance attributes are important, including coatings, resins, elastomers, and engineered materials. Performance Materials is best known for activated carbon technologies, including products used in automotive emissions control systems that help capture gasoline vapor and support compliance with air-quality standards.
Ingevity generates most of its revenue in North America, though its customer base and end markets are global in nature. The company’s results are affected by industrial production levels, automotive demand, raw material and energy costs, environmental regulation, infrastructure spending, and pricing conditions in specialty chemicals. Its competitive position rests on technical expertise, application know-how, customer relationships, and the ability to supply materials that solve specific performance and sustainability challenges.
Last updated
- Market Cap
- 2.34B
- P/E
- —
- P/FCF
- 9.5
- P/S
- 1.93
- Enterprise Value
- 3.44B
- Sector
- —
- Industry
- —
- Address
- 4920 O'HEAR AVENUE, NORTH CHARLESTON, SC, 29405
Ingevity's (NGVT) Earnings and Revenues Miss Estimates in Q2
Ingevity (NGVT), Ultrapolymers Tie-Up for Capa Bioplastics Sales - Zacks Investment Research
Ingevity finalizes termination of key supply agreement By Investing.com - Investing.com
Ingevity (NGVT) Down 12.4% Since Last Earnings Report: Can It Rebound?
Hawkins (HWKN) Earnings Lag Estimates in Q4, Revenues Beat
American Vanguard (AVD) Q1 Earnings Beat, Sales Miss Estimates
Innospec's (IOSP) Q1 Earnings Surpass Estimates, Sales Lag
Valvoline's (VVV) Earnings and Revenues Beat Estimates in Q2
Ingevity's (NGVT) Earnings and Revenues Beat Estimates in Q1
Linde's (LIN) Q1 Earnings Beat Estimates on Higher Pricing
Ingevity (NGVT) Reports Q1 Earnings: What Key Metrics Have to Say
Ingevity (NGVT) Q1 Earnings and Revenues Surpass Estimates
Wil Higher Uranium Prices Aid Energy Fuels' (UUUU) Q1 Earnings?
Olin's (OLN) Earnings and Revenues Beat Estimates in Q1
Air Products (APD) Earnings Beat, Revenues Miss Estimates in Q2
Albemarle (ALB) to Report Q1 Earnings: What's in the Cards?
Will Lower Production Weigh on Barrick's (GOLD) Q1 Earnings?
WestRock (WRK) to Report Q2 Earnings: What's in the Offing?
Mosaic (MOS) to Report Q1 Earnings: What's in the Offing?
DuPont (DD) Gears Up for Q1 Earnings: What's in the Cards?
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 2.34B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 3.44B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 60.04
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 1.93
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 9.61
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 2.84
- EPS
- -3.68
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 9.5
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 7.69
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 245.8M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -328.53%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -7.74%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 30.96
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1.21
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.72
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.23
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 240.34K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 67.17
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 258M | 255.1M | 333.1M | 365.1M | 247.9M |
| Gross profit | 116.4M | 87.8M | 133.9M | 137.9M | 111.9M |
| Operating income | 46.1M | -73.2M | 81.8M | -119.8M | 57M |
| EBITDA | 69.3M | 66.7M | 110.8M | 111.5M | 83.8M |
| Net income | 59.8M | -84.6M | 43.5M | -146.5M | 20.5M |
| Basic EPS | 1.7 | -2.34 | 1.2 | -4.02 | 0.56 |
| Diluted EPS | 1.66 | -2.34 | 1.18 | -4.02 | 0.56 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 1.65B | 1.65B | 1.83B | 1.88B | 2.06B |
| Total liabilities | 1.61B | 1.62B | 1.7B | 1.76B | 1.82B |
| Total equity | 38.9M | 29.7M | 138.1M | 120.7M | 234.6M |
| Cash & equivalents | 95.4M | 78.1M | 83.4M | 76.9M | 71.5M |
| Current assets | 496.7M | 454.2M | 522.2M | 536M | 530M |
| Current liabilities | 409.4M | 338.9M | 413.8M | 393.1M | 264.6M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -2M | 97.1M | 129.7M | 79M | 25.4M |
| Investing cash flow | 106.3M | -15.1M | -28.1M | -2.8M | -11.5M |
| Financing cash flow | -61.8M | -83.4M | -94.8M | -63M | -11M |
| Change in cash | 42.7M | -1.8M | 7.3M | 16.2M | 4.3M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | SCHEDULE 13G/A — Ingevity Corp | View Filing | |
| edgar index | S-8 — Ingevity Corp | View Filing | |
| edgar index | 10-Q — Ingevity Corp | View Filing | |
| edgar index | 8-K — Ingevity Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 8-K — Ingevity Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| form 4 | Form 4 — PLATT PHILLIP JOHN | View Filing | |
| form 4 | Form 4 — NARWOLD KAREN G | View Filing | |
| form 4 | Form 4 — Hoechner Bruce D. | View Filing | |
| form 4 | Form 4 — WILLIS J KEVIN | View Filing | |
| form 4 | Form 4 — Lynch Frederick J | View Filing | |
| form 4 | Form 4 — Gulyas Diane H. | View Filing | |
| form 4 | Form 4 — Gulyas Diane H. | View Filing | |
| form 4 | Form 4 — FERNANDEZ-MORENO LUIS M | View Filing | |
| form 4 | Form 4 — Wright Benjamin G. | View Filing | |
| form 4 | Form 4 — Segal Francis David | View Filing | |
| edgar index | SCHEDULE 13G — Ingevity Corp | View Filing | |
| edgar index | 8-K — Ingevity Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| form 4 | Form 4 — Li David H | View Filing | |
| form 4 | Form 4 — Li David H | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| form 4 | Form 4 — WILLIS J KEVIN | View Filing | |
| form 4 | Form 4 — Segal Francis David | View Filing | |
| edgar index | 8-K — Ingevity Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G/A — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| form 4 | Form 4 — Fisher Ryan C. | View Filing | |
| edgar index | DEF 14A — Ingevity Corp | View Filing | |
| edgar index | DEFA14A — Ingevity Corp | View Filing | |
| edgar index | ARS — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| edgar index | 4 — Ingevity Corp | View Filing | |
| form 4 | Form 4 — DYER TERRANCE M | View Filing | |
| form 4 | Form 4 — Hall Mary Dean | View Filing | |
| form 4 | Form 4 — Hall Mary Dean | View Filing | |
| form 4 | Form 4 — Hall Mary Dean | View Filing | |
| form 4 | Form 4 — Hall Mary Dean | View Filing | |
| form 4 | Form 4 — PLATT PHILLIP JOHN | View Filing | |
| form 4 | Form 4 — PLATT PHILLIP JOHN | View Filing | |
| form 4 | Form 4 — PLATT PHILLIP JOHN | View Filing | |
| form 4 | Form 4 — PLATT PHILLIP JOHN | View Filing | |
| form 4 | Form 4 — White Richard Allen JR | View Filing | |
| form 4 | Form 4 — White Richard Allen JR | View Filing | |
| form 4 | Form 4 — White Richard Allen JR | View Filing | |
| form 4 | Form 4 — White Richard Allen JR | View Filing | |
| form 4 | Form 4 — Fisher Ryan C. | View Filing | |
| form 4 | Form 4 — Fisher Ryan C. | View Filing | |
| form 4 | Form 4 — Fisher Ryan C. | View Filing |